Net Income (Loss) Attributable to Parent in USD of Baudax Bio, Inc. from Q1 2018 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Baudax Bio, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and change rate from Q1 2018 to Q3 2023.
  • Baudax Bio, Inc. Net Income (Loss) Attributable to Parent for the quarter ending 30 Sep 2023 was -$1,934,000.000, a 93.4% increase year-over-year.
  • Baudax Bio, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending 30 Sep 2023 was -$7,153,000.000, a 64.4% increase year-over-year.
  • Baudax Bio, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$58,795,000.000, a 197% decline from 2021.
  • Baudax Bio, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$19,769,000.000, a 74% increase from 2020.
  • Baudax Bio, Inc. annual Net Income (Loss) Attributable to Parent for 2020 was -$76,100,000.000, a 134% decline from 2019.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Change (%)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Change (%)

Baudax Bio, Inc. Quarterly Net Income (Loss) Attributable to Parent (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2023 -$7,153,000 -$1,934,000 +$27,273,000 +93.4% 01 Jul 2023 30 Sep 2023 10-Q 20 Nov 2023
Q2 2023 -$34,426,000 -$7,375,000 +$156,000 +2.1% 01 Apr 2023 30 Jun 2023 10-Q 20 Nov 2023
Q1 2023 -$34,582,000 $11,404,000 +$24,213,000 01 Jan 2023 31 Mar 2023 10-Q 20 Nov 2023
Q4 2022 -$58,795,000 -$9,248,000 -$38,682,000 -1.3% 01 Oct 2022 31 Dec 2022 8-K 28 Jun 2023
Q3 2022 -$20,113,000 -$29,207,000 -$12,245,000 -72.2% 01 Jul 2022 30 Sep 2022 10-Q 20 Nov 2023
Q2 2022 -$7,868,000 -$7,531,000 +$7,798,000 +50.9% 01 Apr 2022 30 Jun 2022 10-Q 20 Nov 2023
Q1 2022 -$15,666,000 -$12,809,000 +$4,103,000 +24.3% 01 Jan 2022 31 Mar 2022 10-Q 20 Nov 2023
Q4 2021 -$19,769,000 $29,434,000 +$46,476,000 01 Oct 2021 31 Dec 2021 8-K 28 Jun 2023
Q3 2021 -$66,245,000 -$16,962,000 -$28,647,000 -2.5% 01 Jul 2021 30 Sep 2021 10-Q 08 Nov 2022
Q2 2021 -$37,598,000 -$15,329,000 +$15,116,000 +49.6% 01 Apr 2021 30 Jun 2021 10-Q 08 Nov 2022
Q1 2021 -$52,714,000 -$16,912,000 +$23,386,000 +58% 01 Jan 2021 31 Mar 2021 10-Q 08 Nov 2022
Q4 2020 -$76,100,000 -$17,042,000 -$9,717,000 -1.3% 01 Oct 2020 31 Dec 2020 10-K 16 Mar 2022
Q3 2020 -$66,383,000 $11,685,000 +$22,000,000 01 Jul 2020 30 Sep 2020 10-Q 04 Nov 2021
Q2 2020 -$88,383,000 -$30,445,000 -$19,863,000 -1.9% 01 Apr 2020 30 Jun 2020 10-Q 04 Nov 2021
Q1 2020 -$68,520,000 -$40,298,000 -$35,963,000 -8.3% 01 Jan 2020 31 Mar 2020 10-Q 04 Nov 2021
Q4 2019 -$32,557,000 -$7,325,000 +$9,356,000 +56.1% 01 Oct 2019 31 Dec 2019 10-K 16 Feb 2021
Q3 2019 -$41,913,000 -$10,315,000 +$8,777,000 +46% 01 Jul 2019 30 Sep 2019 10-Q 09 Nov 2020
Q2 2019 -$50,690,000 -$10,582,000 +$9,855,000 +48.2% 01 Apr 2019 30 Jun 2019 10-Q 09 Nov 2020
Q1 2019 -$60,545,000 -$4,335,000 +$13,122,000 +75.2% 01 Jan 2019 31 Mar 2019 10-Q 09 Nov 2020
Q4 2018 -$73,667,000 -$16,681,000 01 Oct 2018 31 Dec 2018 10-K 13 Feb 2020
Q3 2018 -$19,092,000 01 Jul 2018 30 Sep 2018 10-Q 14 Nov 2019
Q2 2018 -$20,437,000 01 Apr 2018 30 Jun 2018 10-Q 14 Nov 2019
Q1 2018 -$17,457,000 01 Jan 2018 31 Mar 2018 10-Q 14 Nov 2019

Baudax Bio, Inc. Annual Net Income (Loss) Attributable to Parent (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2022 -$58,795,000 -$39,026,000 -2% 01 Jan 2022 31 Dec 2022 8-K 28 Jun 2023
2021 -$19,769,000 +$56,331,000 +74% 01 Jan 2021 31 Dec 2021 8-K 28 Jun 2023
2020 -$76,100,000 -$43,543,000 -1.3% 01 Jan 2020 31 Dec 2020 10-K 16 Mar 2022
2019 -$32,557,000 +$41,110,000 +55.8% 01 Jan 2019 31 Dec 2019 10-K 16 Feb 2021
2018 -$73,667,000 01 Jan 2018 31 Dec 2018 10-K 13 Feb 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.